Comparison Chart Tempus AI, Inc.

Stocks

TEM

US88023B1035

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 24/10/2026 am IST			5-day change	1st Jan Change
67.62 ^USD	+5.96%		+4.47%	+14.50%

24/10	Tempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data	CI
24/10	Pathos AI Announces Strategic Collaborations With Bristol Myers Squibb And Tempus AI, Inc. To Advance AI-Driven Drug Development Beginning With Alzheimer?s Disease And Other Neurological Conditions	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	TEMPUS AI, INC.	Other Biotechnology & Medical Research	+5.96%	+4.47%	+14.50%	-22.31%	-	1.22TCr